|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.780 USD | -5.03% |
|
-6.67% | -30.87% |
| 13/05 | Bolt Biotherapeutics reports first quarter 2026 financial results | RE |
| 13/05 | Bolt Biotherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -5.03% | -6.67% | -17.11% | -23.01% | -30.87% | -38.93% | -86.40% | -98.69% | - | 72.64L | |
| +1.84% | -0.66% | +23.66% | +15.96% | +36.03% | +59.82% | +94.48% | -23.27% | - | 5.49TCr | |
| +0.55% | -5.58% | +0.84% | +13.38% | +7.09% | +57.49% | +130.72% | +194.21% | +5,594.36% | 5.46TCr | |
| -2.24% | +3.59% | +18.15% | -25.32% | -33.57% | +17.75% | +469.23% | +309.24% | +930.39% | 2.51TCr | |
| -1.60% | -6.21% | +1.05% | -4.20% | -3.90% | -18.96% | -16.06% | -57.58% | - | 2.31TCr | |
| -1.69% | -1.27% | +20.70% | +5.78% | +18.70% | +39.51% | -8.30% | -71.58% | - | 1.99TCr | |
| +0.41% | +2.74% | +17.79% | +4.57% | -7.38% | +36.84% | -27.43% | -31.65% | +58.71% | 1.75TCr | |
| -6.84% | +2.18% | +50.20% | +120.65% | +203.28% | +195.12% | +364.56% | +1,625.01% | +698.91% | 1.65TCr | |
| -2.42% | -3.72% | +20.23% | +3.45% | +28.51% | +47.02% | +635.77% | - | - | 1.57TCr | |
| -1.05% | +1.16% | +6.34% | +27.63% | +28.91% | +25.95% | +191.69% | +213.54% | +594.53% | 1.42TCr | |
| -4.16% | +1.63% | +11.63% | +3.29% | -7.84% | +70.13% | +143.42% | +411.05% | - | 1.24TCr | |
| -1.49% | -1.10% | +8.85% | -22.47% | -12.81% | -39.00% | +622.75% | +105.25% | +103.60% | 1.18TCr | |
| -1.39% | -1.87% | +20.98% | +30.55% | +33.57% | +129.32% | +140.49% | +340.88% | +756.41% | 1.15TCr | |
| -2.06% | -6.53% | +6.60% | -30.88% | -15.71% | -19.42% | +152.32% | +56.79% | - | 1.14TCr | |
| -9.05% | -9.04% | +2.52% | +17.29% | +15.08% | +317.26% | +125.24% | +16.14% | +1,205.98% | 1.08TCr | |
| +0.06% | +0.14% | +0.53% | +20.60% | +23.17% | +53.10% | +192.56% | - | - | 982.96Cr | |
| -2.79% | -6.94% | +13.31% | -25.61% | +13.54% | +27.83% | +84.95% | -21.99% | - | 922.19Cr | |
| -0.05% | +97.92% | +142.47% | +111.92% | +79.55% | +161.76% | +318.53% | +303.38% | - | 881.27Cr | |
| -7.33% | -12.92% | +15.77% | +12.91% | +315.15% | +192.53% | +212.55% | -35.07% | - | 860.92Cr | |
| -1.02% | +12.82% | +20.98% | +90.56% | +198.35% | +522.94% | +610.84% | -44.94% | -6.91% | 859.49Cr | |
| Average | -1.92% | +3.46% | +19.28% | +17.35% | +44.44% | +91.90% | +217.59% | +177.26% | +1,104.00% | 1.72TCr | |
| Weighted average by Cap. | -1.02% | +0.88% | +17.64% | +15.41% | +33.32% | +74.40% | +198.02% | +177.09% | +2,184.51% |
- Stock Market
- Stocks
- BOLT Stock
- Sector Bolt Biotherapeutics, Inc.
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition